Skip to content
thestock.space

On 6 Nov 2026, Jeena Sikho Lifecare was priced at ₹322.30, or 17.0× trailing earnings, against an industry P/E of 47.7×, and the shares are 60% below their 52-week high. Sales and net profit grew 58% and 87% a year over 3 years; its ROCE of 54% is the highest among the 7 largest Medical Care Facilities peers. Debt is 0.27× equity, and its dividend yield is 1.4%. It is a small-cap company with a market cap of ₹4,007 Cr, ranked 16th of 40 Medical Care Facilities companies by market cap; the shares fell 56% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹345.25
Day high
₹345.25
Day low
₹315.35
Prev. close
₹345.25
Volume
11.4 L

Health check

4 good · 2 to check
  • ReturnsBehind

    −55.9% over a year, better than 0 of 7 peers.

  • Price tagCheaper

    P/E 17.0 vs industry 47.7.

  • GrowthStrong

    Sales +57.6%, profit +87.3% a year over 3 years.

  • ProfitabilityStrong

    ROCE 54.5% vs peer median 11.9%.

  • Balance sheetSolid

    Debt 0.27× equity, interest covered 24.3×, Piotroski 9 of 9.

  • Red flags1 to check

    60% below its 52-week high.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Small cap

₹4,007 Cr, #16 of 40 in its industry by size.

High beta

Beta 1.22 vs the NIFTY 50: swings more than the market.

Key metrics

Last 12 months to Jun 2026: sales ₹851 Cr · profit ₹237 Cr
Market cap
₹4,007 Cr
Small cap
P/E
17.0
Industry 47.7
Price to book
8.58
Peers 8.06
Dividend yield
1.40%
ROE
61.3%
Peers 12.8%
ROCE
54.5%
Peers 11.9%
Debt to equity
0.27
Debt ₹127 Cr
EPS (TTM)
₹18.98
Face value ₹2
OPM (TTM)
42.6%
Net margin 27.8%
Sales growth
+28.8%
Latest quarter vs a year ago
Profit growth
+28.6%
Latest quarter vs a year ago
Price to sales
4.71
EV/EBITDA 10.7

Strengths and risks

Strengths

  • Return on equity of 61.3%.
  • Return on capital employed of 54.5%.
  • Quarterly profit up 28.6% on a year ago.
  • Quarterly sales up 28.8% on a year ago.
  • Net margin of 27.8%.

Risks to check

  • 60% below its 52-week high.

Derived automatically from reported figures. Not a recommendation.

About Jeena Sikho Lifecare

Jeena Sikho Lifecare Limited trades in ayurvedic products in India and internationally. It operates through Ayurvedic products/medicine, Ayurvedic healthcare services, and others segments. The company offers ayurvedic products under the Shuddhi brand name. It also provides services, including in-patient, out-patient, 72 hours health camps, Panchakarma therapies, dietary support and nutrition guidance, home-based healthcare services, and healthcare support…

Headquarters
Zirakpur
Employees
4,299
Sector
Healthcare
ISIN
INE0J5801029
Website
jeenasikho.com

Price range

52 weeks

₹315.35₹809.00

Today

₹315.35₹345.25
Avg volume (3M)
7.5 L
1-year return
minus 55.9%
From 52-week high
minus 60.2%

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
JSLLJeena Sikho Lifecare322.30minus 6.65%4,00717.08.5854.5%61.3%42.6%57.6%87.3%1.40%minus 55.9%
Median of 7 peers–−0.65%62,09260.48.0611.9%12.8%18.5%16.5%14.7%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Sep 25Dec 25Mar 26Jun 26
174190222216224
95.597.8121138132
78.89210177.992.1
45.2%48.5%45.4%36.1%41.0%
1.11.42.63.414.3
1.74.33.13.73.5
9.710.411.316.415.4
68.578.788.961.287.5
25.2%25.4%25.1%26.4%24.7%
51.358.866.745.165.9
4.124.725.353.625.29

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+57.6%
Profit CAGR 3Y
+87.3%
EPS CAGR 3Y
+86.6%
ROE
61.3%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
204324469799
–+59.1%+44.6%+70.4%
155231327446
49.493142353
24.2%28.7%30.2%44.2%
1.34.32.92.6
0.50.110.212.7
3.15.129.147.7
−2.51.82.22.3
44.593.9108297
24.2%26.3%25.7%25.5%
33.769.279.9222
–+105.1%+15.5%+177.5%
2.745.576.4217.81

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
13.824.924.924.9
112161231442
0.857.7117127
24.428.645.779.9
151272419674
66.9127205235
7.23.5122.7
––2.816.4
36.265.726.1225
40.875.7174196
151272419674

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
17.236.784.5254
−57.2−18−64.5−202
48−3.4−22.5−58.7
7.915.2−2.4−6.6
−38.2−15.5−42.3−34.1
−2121.242.2220
–−2.8−10.4−13.7

Shareholding pattern

Source: NSE filings
63.7%
promoters
  • Promoters63.67%
  • Public36.33%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202663.67%36.33%plus 0.05
30 Jun 202663.62%36.38%0.00
31 Mar 202663.62%36.38%0.00
31 Dec 202563.62%36.38%plus 0.01
30 Sep 202563.61%36.39%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you